Press Room

News / Mar 08, 2021

2021 International Women's Day - Read statements

Choose To Challenge

2021 International Women's Day | Hovione

This year’s theme for International Women’s Day is #ChooseToChallenge to celebrate the achievements of women around the world.

Today Hovione women also #ChooseToChallenge. From Portugal to the USA, Ireland, Macau and India, we celebrate our team’s achievements.

Thank you to Beatriz Noriega Fernandes, Camie Lou, Kristen Parisi, Linda Cullinane, Louise Dennehy, Madhu Gautam, Mafalda Paiva, Marianna Katz, Marilena Ornelas, Mary Hennessy, Sarah Downing, Sarah Scott, Sónia Cardoso and Tânia Dias for raising their hands high. 

From challenge comes change. Read their statements here.

 

O tema deste ano do Dia Internacional da Mulher é #ChooseToChallenge - Escolher Desafiar - para celebrar as

conquistas das mulheres em todo o mundo.

As mulheres Hovione também aderiram à campanha #ChooseToChallenge. De Portugal aos EUA, Irlanda, Macau e Índia, celebramos as conquistas da nossa equipa.

 

Obrigada Beatriz Noriega Fernandes, Camie Lou, Kristen Parisi, Linda Cullinane, Louise Dennehy,

Madhu Gautam, Mafalda Paiva, Marianna Katz, Marilena Ornelas, Mary Hennessy, Sarah Downing,

Sarah Scott, Sónia Cardoso e Tânia Dias por levantarem as vossas mãos.

Do desafio vem a mudança. Leia os seus testemunhos aqui.

2021 International Women's Day_ Kristen Parisi | Hovione

 

  

My name is Kristen and I’m a HR Business Partner at Hovione USA.

My journey at Hovione has been one of my proudest professional achievements.

I started June of 2017 in the capacity of a split role, supporting HR initiatives while maintaining office management.

I have since been promoted twice and currently hold the role of HR Business Partner.

Hovione provides the necessary tools and opportunities for TM’s to have a fulfilling and challenging career.

O meu nome é Kristen e sou HR Business Partner na Hovione EUA.

O meu trajeto na Hovione é uma das conquistas profissionais de que mais me orgulho.

Comecei em junho de 2017 a apoiar iniciativas de RH enquanto mantinha a gestão do escritório.

Desde então, fui promovida duas vezes e atualmente exerço a função de HR Business Partner.

A Hovione fornece as ferramentas e oportunidades necessárias para que as Colaboradoras tenham uma carreira gratificante e desafiadora.

Kristen Parisi - HR Business Partner

Hovione USA
2021 International Women's Day Madhu Gautam | Hovione

 

  

My name is Madhu and I’m a Director at Hovione India office.

I believe in a world where everyone – regardless of their age, gender, religion, disability, sexual orientation, or ethnicity - is provided with equal opportunities and I share this belief with Hovione.

To all my colleagues around the world I raise my hand: by working at Hovione we have committed ourselves to save lives and improve the quality of life of millions of patients.

There is no limit to what we can do together. Be proud. Be happy!

O meu nome é Madhu e sou diretora do escritório da Hovione Índia.

Acredito num mundo onde todos - independentemente da sua idade, sexo, religião, incapacidade, orientação sexual ou etnia - tenham oportunidades iguais e partilho esta convicção com a Hovione.

A todas as minhas colegas em todo o mundo, levanto a minha mão: ao trabalhar na Hovione, comprometemo-nos a salvar vidas e a melhorar a qualidade de vida de milhões de pacientes.

Não há limite para o que podemos fazer em conjunto. Tenham orgulho. Sejam felizes!

Madhu Gautam - Director of Hovione India

Hovione India
2021 International Women's Day | Hovione

 

  

My name is Camie Lou and I’m the Administrative Manager at Hovione Macau.

I am proud to be part of a workplace where everyone is welcomed and so many women have the opportunity to achieve their full potential.

I am challenged every day to perform my best and to all my colleagues around the world, I raise my hand: celebrate daily your personal and professional achievements.

Let’s celebrate this day together!

O meu nome é Camie e sou Administrative Manager na Hovione Macau.

Tenho orgulho de fazer parte de uma empresa onde todos são bem-vindos e onde muitas mulheres têm a oportunidade de atingir todo o seu potencial.

Sou desafiada todos os dias a dar o meu melhor e para todas as minhas colegas em qualquer parte do mundo levanto a mão: comemorem diariamente as vossas conquistas pessoais e profissionais.

Vamos comemorar este dia juntas!

Camie Lou - Administrative Manager

Hovione Macau
2021 International Women's Day Ireland Team| Hovione

 

  

At Hovione Eireann, we are very proud of our diverse and inclusive culture and love to find ways to celebrate it.

One aspect of our diversity is our gender balance across our teams and at all levels of the organization and therefore we have again decided to plan an event to celebrate the annual ‘International Women's Day’ on Monday March 8th.

We will host a virtual art class, during which we will design a card to send to a woman who inspires us.

In keeping with this year’s theme, #choosetochallenge, we are challenging ourselves to try something new and creative, keeping in mind the importance of ensuring everyone on our teams has a voice.

This year our event is in aid of Cuanlee, a women's refuge in Cork city which has seen a big increase in calls for help this year due to the lockdowns over the past 12 months.

We hope our contribution towards them helps in some way with the challenges they face every day.

Na Hovione Irlanda, temos muito orgulho da nossa cultura diversificada e inclusiva e adoramos encontrar formas de a celebrar.

Um aspeto da nossa diversidade é o equilíbrio de género nas nossas equipas e em todos os níveis da organização e, por isso, decidimos novamente planear um evento para celebrar o ‘Dia Internacional da Mulher’ na segunda-feira, 8 de março.

Faremos uma aula de arte virtual, durante a qual desenharemos um cartão para enviar a uma mulher que nos inspire.

De acordo com o tema deste ano, #choosetochallenge, estamos a desafiar-nos para tentar algo novo e criativo, tendo em mente a importância de garantir que todos nas nossas equipas têm uma voz.

Este ano, o nosso evento irá apoiar a Cuanlee, um refúgio feminino na cidade de Cork, que teve um grande aumento no número de pedidos de ajuda devido aos confinamentos dos últimos 12 meses.

Esperamos que a nossa contribuição as possa ajudar a enfrentar os desafios de todos os dias.

Mary Hennessy - Director of Human Resources Ireland

Louise Dennehy - HR Business Partner, Linda Cullinane - Supply Chain Director, Sarah Downing - QA Director,

Sarah Scott - Product Quality Manager

Hovione Ireland
2021 International Women's Day | Hovione

 

  

My name is Tânia and I’m an Events Coordinator at Hovione Portugal.

In my professional career, I have always achieved my goals, always keeping an attitude based of humility, integrity, and an open mind!

Joining Hovione was one of those goals, and it has brought me new experiences, both professionally and personally.

O meu nome é Tânia e sou Events Coordinator na Hovione Portugal.

No meu percurso profissional, tenho lutado sempre para concretizar as metas a que me proponho, seguindo sempre a minha visão pessoal de humildade, integridade e otimismo!

A entrada na Hovione foi uma dessas metas, que me tem trazido novas experiências quer a nível profissional como pessoal.

Tânia Dias - Events Coordinator

Hovione Portugal
2021 International Women's Day | Hovione

 

  

My name is Mafalda and I am a proud scientist at Hovione R&D Portugal.

My journey here began six years ago, as an analytical chemist, and evolved to management positions, all within R&D.

I am passionate about science, business and people!

I truly believe that we can all achieve our goals and pursue our passions, if we truly work for it, independent of gender, race, sexual orientation or religion.

The sky is, indeed, the limit!

O meu nome é Mafalda e sou uma orgulhosa cientista na Hovione Portugal.

A minha viagem começou aqui há seis anos, como analytical chemist, e evoluiu para cargos de gestão, tudo dentro da área de R&D.

Sou apaixonada pela ciência, negócios e pessoas!

Acredito verdadeiramente que todos podemos alcançar os nossos objetivos e seguir as nossas paixões, se realmente trabalharmos para isso, independentemente do género, raça, orientação sexual ou religião.

O céu é, de facto, o limite!

Mafalda Paiva - Group Leader, R&D Analytical Development

Hovione Portugal
2021 International Women's Day | Hovione

 

  

My name is Marilena and I’m an Operational Excellence Engineer at Hovione Portugal.

I always thought that to practice cross fit you had to be very strong and a bit crazy.

Guess what, I am one of the crazy ones, and all I needed was to step out of my comfort zone, to practice a lot and never give up.

O meu nome é Marilena e sou Operational Excellence Engineer na Hovione Portugal.

Sempre achei que para praticar cross fit era necessário ser uma pessoa muito forte e louca.

Adivinhem, eu sou uma das loucas, e tudo o que eu precisava era sair da minha zona de conforto, praticar muito e nunca desistir.

Marilena Ornelas - Operational Excellence Engineer

Hovione Portugal
2021 International Women's Day | Hovione

 

  

My name is Beatriz and I’m a scientist at Hovione Portugal.

From a small town to the capital, from engineering to pharmaceutical development, I feel a sense of accomplishment knowing my everyday small tasks help to save lives.

I was lucky to be born in a place where I had all the opportunities available for me, however this is still not the case for so many women all around the world.

I will continue to speak up for them. 

O meu nome é Beatriz e sou cientista na Hovione Portugal.

De uma pequena cidade à capital, da engenharia ao desenvolvimento farmacêutico, sinto-me realizada por saber que as minhas pequenas tarefas diárias ajudam a salvar vidas.

Tive a sorte de nascer com todas as oportunidades à minha espera, mas esse ainda não é o caso de muitas mulheres em todo o mundo.

Por elas, continuarei a falar.

Beatriz Noriega Fernandes - Scientist, R&D DPD Inhalation

Hovione Portugal
2021 International Women's Day | Hovione

 

  

My name is Sónia and I work at RDP Analytical Sciences at Hovione Portugal.

I feel glad to be able to enjoy a fulfilled life by combining the things that I love most: family, science and helping others.

O meu nome é Sónia e trabalho na área de RDP Analytical Sciences na Hovione Portugal.

Estou feliz por ter uma vida plena ao combinar as coisas que mais amo: família, ciência e ajudar os outros.

Sónia Cardoso - RDP Analytical Sciences

Hovione Portugal
International Women Day Scientists testimonial | Hovione

 

  

My name is Marianna and I'm a Scientist at Hovione Portugal.

Study hard. Play the cello. Move abroad. Run a half marathon.

Explore different cultures. Work hard. Do a headstand. Innovate. Have fun.

Change lives. Love. Choose to challenge. The sky is the limit.

Women are versatile, support and acknowledge them!

O meu nome é Marianna e sou cientista na Hovione Portugal.

Estuda muito. Toca violoncelo. Muda de país. Corre uma meia maratona.

Explora diferentes culturas. Trabalha no duro. Pratica headstand. Inova. Diverte-te.

Muda vidas. Ama. Escolhe desafiar. O céu é o limite.

As mulheres são versáteis, vamos apoiá-las e reconhecê-las!

Marianna Katz - Scientist – R&D Products

Hovione Portugal

 

 

 

 

 

 

 

Also in the Press Room

See All

The investment includes both continuous and batch tableting capabilities, as well as connect spray drying with tablet production at its East Windsor campus. Hovione, a Portugal-based contract development and manufacturing organization (CDMO), plans to install a continuous tableting line at its East Windsor, New Jersey campus, adding drug product manufacturing capacity and an integrated pathway from amorphous solid dispersion production through commercial tablet manufacturing. The $35 million investment will bring the first ConsiGma CDC Flex system to Hovione’s recently opened 89 Twin Rivers facility. The line is expected to be commissioned in late 2027 and will support both continuous and batch operation at throughputs ranging from 1 to 200 kilograms per hour, according to the announcement. The system will allow customers to use the same equipment for development, clinical, and commercial production, with formulation development possible using as little as 1.5 kilograms of material. Hovione said the line will also be equipped for containment to 1 microgram per cubic meter to support the handling of highly potent compounds. The new capability will also connect Hovione’s spray-drying operations with tablet manufacturing at the East Windsor campus. The company recently opened a 31,000-square-foot facility at the campus with two commercial-scale spray dryers for manufacturing amorphous solid dispersions (ASDs), completing a $100 million investment in its New Jersey operations. Hovione said the integrated setup will allow customers to move from formulation and particle engineering through tablet production under one quality system, reducing technology transfer requirements and eliminating traditional scale-up between development and commercial production. The ConsiGma CDC Flex platform was jointly developed with GEA as part of a collaboration that began in 2022, the company said. The system incorporates automated process controls and process analytical technology for real-time monitoring during production. Hovione already operates continuous tableting technology at its Loures, Portugal site. In August, the company completed a more than €40 million expansion of its tablet development and manufacturing center there, adding a second commercial-scale tableting line and increasing the center's manufacturing area by 25%. The East Windsor installation will extend Hovione’s continuous tableting capabilities to the U.S. and expand its integrated drug development and manufacturing services for oral solid dosage products. Read the full article at Pharma Manufacturing 

Press Clipping
Pharma Manufacturing, 6 October 2026

Hovione to add $35M continuous tableting line at New Jersey site

Oct 06, 2026

Hovione, a globally integrated pharmaceutical contract development and manufacturing organisation (CDMO), will commission the world’s first ConsiGma CDC flex – a next generation continuous tableting line – at its East Windsor, New Jersey (USA) campus in late 2027. The line will be installed at 89 Twin Rivers, Hovione’s recently opened facility, expanding the company’s drug product capabilities and strengthening its integrated pharmaceutical development and manufacturing hub in the US. CDC ConsiGma flex system The project represents an investment of $35 million. Once installed it will create an integrated pathway from amorphous solid dispersion manufacturing via spray drying through commercial tablet production. The new flex will operate in continuous or batch modes across a very broad throughput range (from one to 200 kg/h). Customers will be able to develop a formulation using small quantities of material, down to 1.5 kg, and then run from very small clinical batches to large commercial batches using the same equipment. This is enabled by specialised design within the flex to effectively switch between continuous blenders of various sizes. Additionally, the line will be installed for containment to 1 µg/m³, supporting highly potent compounds. Continuous tableting is reshaping manufacturing of oral solid dosage medicines and is well suited to programmes in which speed, supply resilience and efficient use of high-value active pharmaceutical ingredients (APIs) are priorities. Inline process analytical technology (PAT) and automated controls also provide real-time quality monitoring. In parallel, the 2022 adoption of ICH Q13 regulatory framework, guidance specifically for continuous manufacturing of drug substances and drug products, provides harmonisation across the US, Europe and Japan. As of 2024, 17 products manufactured under the international guidance have been approved by the US Food and Drug Administration (FDA) alone.  Developed jointly with GEA, the ConsiGma CDC flex platform also incorporates SimpleCT, a suite of automation and control tools with smart interfaces that supports a single process from development to commercial supply. Designed for versatility and ease of use, these innovative developments simplify operation, improve efficiency and containment, and enhance operator safety. Read the full article at Pharma Press UK 

Press Clipping
Pharma Press Global, 6 October 2026

Hovione to commission world’s first ConsiGma CDC flex, bringing next-generation continuous tableting to the US

Oct 06, 2026

Key Takeaways Commissioning a US-based ConsiGma CDC Flex line enables end-to-end spray drying-to-tablet manufacture within a single site and quality system, reducing comparability and technology-transfer burdens. Elimination of conventional scale-up is enabled by using the same equipment from early development through commercial supply, minimizing engineering runs and conserving scarce API. Operational flexibility spans batch or continuous modes and 1–200 kg/h throughput, with scale adjustment achieved by switching continuous blenders rather than replatforming processes. High-containment design to 1 µg/m³ expands suitability for highly potent oral solid-dose programs while maintaining integrated development-to-commercial workflows. Regulatory momentum for continuous manufacturing is supported by ICH Q13 harmonization, increasing FDA approvals, and platforms leveraging inline PAT and automated control suites for real-time quality assurance. Hovione announced on Oct. 5, 2026, that it will commission the ConsiGma CDC Flex, a next-generation continuous direct compression tableting platform jointly developed with GEA. The investment is designed to link amorphous solid dispersion manufacturing via spray drying with commercial tablet production at a single US site operating under one quality system. The line will run in either continuous or batch mode at throughputs from 1 to 200 kg/h. Formulation development can begin with as little as 1.5 kg of material, and the same equipment can then support everything from very small clinical batches to large commercial runs, enabled by a design that allows the system to switch between continuous blenders of different sizes. The installation will also be contained to 1 µg/m³ to accommodate highly potent compounds. "Hovione will be the first company in the world to offer the ConsiGma® CDC Flex, bringing this next-generation technology with unprecedented flexibility, simplicity and cost-efficiency in continuous tableting," said Marco Gil and António Almeida, co-CEOs, Hovione, said in a press release. "This investment also advances our strategy of building integrated capabilities close to customers in key markets. By adding this new line at East Windsor, we are broadening access to this technology in the U.S. and giving customers a more direct and accelerated path for developing and commercializing complex oral medicines." What Does a Single Development-To-Commercial Line Change? For formulators and process engineers, the most consequential claim is the removal of traditional scale-up. Moving a process from development equipment to commercial equipment typically requires engineering runs, bridging work, and consumption of scarce API, all of which weigh heavily on early programs with limited material. "Installing the CDC Flex at 89 Twin Rivers makes continuous tableting part of an integrated US development and manufacturing workflow," said David Basile, Vice President of Technical Operations, Hovione, in the press release. "Customers can move from formulation and particle engineering to commercial tablets with one Hovione team and one quality system, eliminating traditional scale-up while gaining greater production flexibility, process control and supply continuity." Co-locating spray drying and tableting is also significant because amorphous solid dispersions remain a primary solubility-enhancement route for poorly soluble molecules, and transferring intermediates between sites or vendors adds technology transfer and comparability burdens. The new line builds on the company's earlier US expansion; Hovione recently completed a $100 million investment to bolster US capacity in particle design, amorphous solid dispersions via spray drying, and batch and continuous tableting. How Is the Regulatory Environment Shaping Continuous Tableting Adoption? The company points to the 2022 adoption of ICH Q13, which provides harmonized guidance for continuous manufacturing of drug substances and drug products across the US, Europe, and Japan. Hovione reports that, as of 2024, FDA alone had approved 17 products manufactured under the guidance. Speaking on ICH Q13, FDA's Kelley Burridge, PhD, "Perceived barriers to continuous manufacturing have been falling one by one," and noted an FDA publication showing faster approval times for products with continuous manufacturing elements than for comparable batch products. The platform incorporates inline process analytical technology and automated controls for real-time quality monitoring, along with SimpleCT, an automation and control suite intended to support a single process from development through commercial supply. For sponsors weighing supply resilience and regional sourcing, the East Windsor installation extends a capability that Hovione says only it currently offers as a contract development and manufacturing organization.   Read the full article at PharmTech.com  

Press Clipping
PharmTech, 5 October 2026

Can Continuous Tableting End Scale-Up for Complex Oral Drugs?

Oct 05, 2026

Also in Events

See All